Back to school

News
Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-09-01-2008
Volume 20
Issue 9

It's back to school. Another summer has flown past and here we all meet again, ready to return to work and face the winter with renewed energies. Welcome back!

It's back to school. Another summer has flown past and here we all meet again, ready to return to work and face the winter with renewed energies. Welcome back!

While some of you have been enjoying a well-deserved break during July and August, at Pharmaceutical Technology Europe (PTE) we have continued to work hard, not only to bring you the most up-to-date information regarding the European pharmaceutical and biopharmaceutical industries, but to do so in an exciting, innovative and comprehensive way. This effort has resulted in the creation of new sections, and the implementation of a series of developments and improvements in the PTE magazine and website. We are confident you will enjoy them.

So, what's new? In the PTE magazine we have introduced a brand new section where we'll be tackling strategic business and marketing issues, corporate policy, legislation, finance and much more through interviews, industry reports and opinion articles. This section will be called Business Focus and can be found in pages 85–98.

Additionally, as CPhI/ICSE and Technopharm/PowTech are taking place at the end of the month in Germany, we have dedicated some space in the September issue to preview these events, present the profiles of a number of exhibiting companies and showcase some of the products that will be displayed at the show.

In the PTE website (www.ptemag.com) we have several exciting new developments. Out and About is a new section where the members of the editorial team write their personal impressions of events, trades fairs and congresses, and of visits to manufacturing plants and R&D facilities. From a review of Excipient Fest Europe 2008 to a visit to Almirall in Spain, you can find it at www.ptemag.com/outandabout. Look out for the photographs!

In the Online Exclusives section in our homepage, you will find a series of quick interviews with key members of the pharmaceutical and biopharmaceutical industries, together with additional feature articles and reviews for quick access and reference. Lluis Ribas de Pouplana (Omnia Molecular) and Fraser Black (SAS GE Healthcare) have been two of our 'victims' so far. You can find this section at www.ptemag.com/onlineexclusives.

And last but not least, we have created two new sections to host Case Studies and White Papers. If your company would like to see its case studies and white papers featured on our website, please do not hesitate to get in touch.

In summary, this is a September issue packed to the brim with feature articles, interviews, insights and opinions... Enjoy it! Also, if you are going to CPhI, please come and visit us at Hall 3.1 Stand 31H19. See you in Frankfurt!

Recent Videos
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Related Content